|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lyme Disease Antibody
Test CodeLYM
Includes
If Lyme Disease Antibody, Total, EIA is positive, Lyme Disease Antibodies (IgG, IgM), Western Blot will be performed at an additional charge
Preferred Specimen
1 mL serum
Minimum Volume
0.7 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Refrigerated: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric
Methodology
ELISA
Setup Schedule
Set up per State labs testing requirements
Report Available
3-7 days
Reference Range
Negative
Clinical Significance
Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. A screening test with high sensitivity is used as the first step in the CDC recommended algorithm. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected screening result.